Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease (Q41012770)

25 September 2017

Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease (English)

1 reference

25 September 2017

0 references

4

Carlo Caltagirone

1 reference

25 September 2017

Vincenzo De Luca

1

1 reference

25 September 2017

Maria Donata Orfei

series ordinal

2

1 reference

25 September 2017

Sara Gaudenzi

series ordinal

3

1 reference

25 September 2017

Gianfranco Spalletta

series ordinal

5

1 reference

25 September 2017

29 December 2015

1 reference

European Archives of Psychiatry and Clinical Neuroscience

25 September 2017

1 reference

25 September 2017

266

1 reference

25 September 2017

7

1 reference

25 September 2017

599-606

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-015-0663-4

25 September 2017

0 references

cites work

Genetic aspects of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Apolipoprotein E epsilon4 allele frequency and age at onset of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

The effect of job loss on overweight and drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Disease variants in genomes of 44 centenarians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Age-at-onset in bipolar-I disorder: mixture analysis of 1369 cases identifies three distinct clinical sub-groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

A novel Alzheimer disease locus located near the gene encoding tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Cognitive differences between early- and late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

An admixture analysis of the age at index episodes in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Age at onset in Canadian schizophrenia patients: admixture analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Early onset APOE E4-negative Alzheimer's disease patients show faster cognitive decline on non-memory domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

An admixture analysis of age of onset in agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Admixture analysis of age at onset in obsessive–compulsive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-015-0663-4

Comparison of behavioral and psychological symptoms in early-onset and late-onset Alzheimer's disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26714935

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Epidemiology of Alzheimer disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26714935

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00406-015-0663-4

1 reference

25 September 2017

1 reference